Literature DB >> 14576067

Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1.

Nicolas Prévost1, Donna S Woulfe, Massimiliano Tognolini, Takako Tanaka, Wenying Jian, Ryan R Fortna, Hong Jiang, Lawrence F Brass.   

Abstract

We have previously shown that platelets express 2 receptor tyrosine kinases, EphA4 and EphB1, and the Eph kinase ligand, ephrinB1, and proposed that transcellular Eph/ephrin interactions made possible by the onset of platelet aggregation promote the further growth and stability of the hemostatic plug. The present study examines how this might occur. The results show that clustering of either ephrinB1 or EphA4 causes platelets to adhere to immobilized fibrinogen via alpha(IIb)beta(3). Adhesion occurs more slowly than with adenosine diphosphate (ADP) and requires phosphatidylinositol 3 (PI3)-kinase and protein kinase C activity but not ephrinB1 phosphorylation. By itself, Eph and ephrin signaling is insufficient to cause aggregation or the binding of soluble fibrinogen, but it can potentiate aggregation initiated by a Ca(++) ionophore or by agonists for thrombin and thromboxane receptors. It also enhances Rap1 activation without requiring ADP secretion, ephrinB1 phosphorylation, or the activation of PI3-kinase and Src. From this we conclude that (1) Eph/ephrin signaling enhances the ability of platelet agonists to cause aggregation provided that those agonists can increase cytosolic Ca(++); (2) this is accomplished in part by activating Rap1; and (3) these effects require oligomerization of ephrinB1 but not phosphotyrosine-based interactions with the ephrinB1 cytoplasmic domain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576067     DOI: 10.1182/blood-2003-06-1781

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  A directed miniscreen for genes involved in the Drosophila anti-parasitoid immune response.

Authors:  Laura Howell; Christopher J Sampson; Miguel J Xavier; Ekin Bolukbasi; Margarete M S Heck; Michael J Williams
Journal:  Immunogenetics       Date:  2011-09-27       Impact factor: 2.846

2.  Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contraction.

Authors:  Jurgen A Riedl; Dominique T Brandt; Eduard Batlle; Leo S Price; Hans Clevers; Johannes L Bos
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

3.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

Authors:  Nicolas Prévost; Donna S Woulfe; Hong Jiang; Timothy J Stalker; Patrizia Marchese; Zaverio M Ruggeri; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

Review 4.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  Eph/ephrin signaling: networks.

Authors:  Dina Arvanitis; Alice Davy
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

6.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

7.  Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro.

Authors:  Christian Hafner; Stefanie Meyer; Thomas Langmann; Gerd Schmitz; Frauke Bataille; Ilja Hagen; Bernd Becker; Alexander Roesch; Gerhard Rogler; Michael Landthaler; Thomas Vogt
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

8.  The product of the γ-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis.

Authors:  Noel A Warren; Georgios Voloudakis; Yonejung Yoon; Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

Review 9.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 10.  Harnessing the platelet signaling network to produce an optimal hemostatic response.

Authors:  Lawrence F Brass; Maurizio Tomaiuolo; Timothy J Stalker
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-11       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.